Viewing data from:

MIDAZOLAM HYDROCHLORIDE

ANDA

MIDAZOLAM HYDROCHLORIDE | A075293 | HOSPIRA INC

2 strengths0 unique patents0 unique exclusivities

Citizen Petitions

1 petition from Regulations.gov

Petition	Type	Filed	Status	Petitioner
Alaunus Pharmaceutical, LLC - Citizen Petition FDA-2010-P-0460 · 4 docket documents Alaunus Pharmaceutical, LLC filed this ANDA suitability petition under Section 505(j)(2)(C) requesting FDA permission to submit an Abbreviated New Drug Application for Midazolam Hydrochloride Injection in a 500 mg/100 mL fliptop vial, which differs from the reference listed drug only in total dosage	Other	2010-09-27	GrantedUnverified summary	—

Source: Regulations.gov. FDA citizen petitions matched by application number.

Drug Pricing (NADAC)

National Average Drug Acquisition Cost — Week of 2026-08-26 | 1 NDC

Highest NADAC/Unit

$0.3817

per ml

Lowest NADAC/Unit

$0.3817

per ml

Brand NDCs

Generic NDCs

NDC Description	NADAC/Unit	Unit	Type	Generic NADAC	Effective
00409259605MIDAZOLAM HCL 50 MG/10 ML VIAL	$0.3817	ML	Generic	—	2026-08-19

Source: NADAC (data.medicaid.gov). Prices reflect national average acquisition costs for retail community pharmacies.

API Supply Chain1 active DMF

1 active API supplier hold Drug Master Files for this ingredient. Limited supplier base — potential supply chain risk.

CAMBREX PROFARMACO MILANO SRLMIDAZOLAM HYDROCHLORIDE

DMF 399912024

Source: FDA Drug Master Files (fda.gov). Type II API DMFs matched by ingredient.

Approval Letters

2 letters from Drugs@FDA

Date	Submission	Document
Jun 9, 2004	ORIG -1	View Letter (PDF)
Jun 20, 2000	ORIG -1	View Letter (PDF)

Source: Drugs@FDA application documents.

Products (2)

Sort:

#001 — EQ 1MG BASE/ML

0 patents0 exclusivities▴

INJECTABLE;INJECTION | Approved: Jun 20, 2000

No patent or exclusivity listings for this strength.

#002 — EQ 5MG BASE/ML

0 patents0 exclusivities▾

INJECTABLE;INJECTION | Approved: Jun 20, 2000